AUTHOR=Xu Lidan , Ji Xiumei , Lin Mali , Chen Xipo , Su Chan 

TITLE=Respiratory microbiota diversity and composition in recurrent protracted bacterial bronchitis: a cross-sectional study

JOURNAL=Frontiers in Cellular and Infection Microbiology

VOLUME=Volume 15 - 2025

YEAR=2025

URL=https://www.frontiersin.org/journals/cellular-and-infection-microbiology/articles/10.3389/fcimb.2025.1524116

DOI=10.3389/fcimb.2025.1524116

ISSN=2235-2988

ABSTRACT=IntroductionRecurrent protracted bacterial bronchitis (RPBB) is a significant risk factor for bronchiectasis in children, characterized by multiple episodes of protracted bacterial bronchitis (PBB) annually. With an increasing global incidence, a detailed understanding of RPBB’s pathophysiology is essential, particularly regarding the role of lung microbiota.MethodsThis cross-sectional study recruited 39 children from Jinhua Maternal and Child Health Hospital between January 2021 and December 2022, including 18 with PBB, 11 with RPBB, and 10 as controls. Bronchoscopy with bronchoalveolar lavage (BAL) was performed to collect lung microbiota samples, which were analyzed using 16S rDNA sequencing. Microbial diversity and composition differences among groups were assessed using alpha and beta diversity metrics, PERMANOVA, and Linear Discriminant Analysis Effect Size (LEfSe), with statistical significance set at P < 0.05.ResultsRPBB patients exhibited a distinct lung microbiota composition compared to controls, characterized by an increased abundance of pathogens such as Acinetobacter and Mycoplasma, alongside a reduction in beneficial genera like Streptococcus and Granulicatella. The RPBB group also demonstrated greater overall microbiota diversity, indicating dysbiosis that may contribute to disease severity and persistent respiratory symptoms.ConclusionThis study revealed significant alterations in the lung microbiota of children with RPBB, suggesting that microbial imbalance could play a crucial role in disease pathogenesis. These findings highlight the importance of targeted prevention and therapeutic strategies aimed at restoring microbiota balance to improve pediatric respiratory health.